Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) — Cash Flow Reinvestment Rate
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a Cash Flow Reinvestment Rate of 4.07x as of September 2025, reinvesting CN¥34.84 Million (capex CN¥34.84 Million ) from operating cash flow of CN¥8.57 Million. See Zhejiang Shapuaisi Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Shapuaisi Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2008–2024)
Historical reinvestment intensity for Zhejiang Shapuaisi Pharmaceutical Co Ltd across 17 annual periods. For the full cash flow conversion analysis, see Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Year-by-year capital reinvestment analysis for Zhejiang Shapuaisi Pharmaceutical Co Ltd. See Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.90x | CN¥202.80 Million | CN¥25.67 Million | CN¥128.11 Million | ▲ +4.2% |
| 2023 | 7.58x | CN¥314.65 Million | CN¥41.49 Million | CN¥219.80 Million | ▲ +354.4% |
| 2022 | 1.67x | CN¥193.13 Million | CN¥115.72 Million | CN¥148.69 Million | ▼ -62.5% |
| 2021 | 4.45x | CN¥448.68 Million | CN¥100.78 Million | CN¥153.44 Million | ▲ +46.6% |
| 2020 | 3.04x | CN¥133.91 Million | CN¥44.09 Million | CN¥17.18 Million | ▲ +566.2% |
| 2019 | 0.46x | CN¥27.11 Million | CN¥59.47 Million | CN¥20.33 Million | ▼ -87.4% |
| 2018 | 3.62x | CN¥363.80 Million | CN¥100.37 Million | CN¥58.38 Million | ▼ -15.1% |
| 2017 | 4.27x | CN¥194.50 Million | CN¥45.57 Million | CN¥114.00 Million | ▲ +281.3% |
| 2016 | 1.12x | CN¥329.44 Million | CN¥294.33 Million | CN¥39.94 Million | ▼ -28.1% |
| 2015 | 1.56x | CN¥177.94 Million | CN¥114.27 Million | CN¥97.94 Million | ▲ +124.8% |
| 2014 | 0.69x | CN¥102.53 Million | CN¥147.99 Million | CN¥102.53 Million | ▲ +13.8% |
| 2013 | 0.61x | CN¥71.73 Million | CN¥117.86 Million | CN¥71.73 Million | ▼ -43.1% |
| 2012 | 1.07x | CN¥71.91 Million | CN¥67.27 Million | CN¥71.91 Million | ▼ -45.3% |
| 2011 | 1.95x | CN¥29.59 Million | CN¥15.14 Million | CN¥29.59 Million | ▲ +326.0% |
| 2010 | 0.46x | CN¥8.06 Million | CN¥17.57 Million | CN¥8.06 Million | ▲ +56.1% |
| 2009 | 0.29x | CN¥8.49 Million | CN¥28.87 Million | CN¥8.49 Million | ▼ -74.7% |
| 2008 | 1.16x | CN¥13.01 Million | CN¥11.20 Million | CN¥13.01 Million | — |